In a previous study, we treated an ovarian cancer mouse xenograft with siRNA targeting CD44, and showed that the resulting reduction of CD44 expression in the tumor correlated with decreased expression of P-gp and increased drug cytotoxicity [21]. The gene discussed is PGP; the disease is ovarian cancer.